These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8049303)

  • 21. Reflections: of hope and of concern.
    Anderson FW
    Hum Gene Ther; 1991; 2(3):193-4. PubMed ID: 1751588
    [No Abstract]   [Full Text] [Related]  

  • 22. Debunking the slippery slope argument against human germ-line gene therapy.
    Resnik D
    J Med Philos; 1994 Feb; 19(1):23-40. PubMed ID: 8201288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public oversight is necessary if human gene therapy is to progress.
    Zallen DT
    Hum Gene Ther; 1996 May; 7(7):795-7. PubMed ID: 8860831
    [No Abstract]   [Full Text] [Related]  

  • 24. Green College Lecture. Ethical challenges in embryo manipulation.
    Warnock M
    BMJ; 1992 Apr; 304(6833):1045-9. PubMed ID: 1586793
    [No Abstract]   [Full Text] [Related]  

  • 25. Interventions in the human genome: some moral and ethical considerations.
    Richter G; Bacchetta MD
    J Med Philos; 1998 Jun; 23(3):303-17. PubMed ID: 9736192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human gene therapy and slippery slope arguments.
    McGleenan T
    J Med Ethics; 1995 Dec; 21(6):350-5. PubMed ID: 8778459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Round table discussion 'gene therapy and society'--summary and conclusions.
    Hehlmann R; Odenbach E; Hofschneider PH; Strorhman R; Goldman J; Hausheer H; Takaku F
    Leukemia; 1995 Oct; 9 Suppl 1():S7-8. PubMed ID: 7475318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human gene therapy: application, ethics and regulation.
    Baskerville G
    Dickinson Law Rev; 1992; 96(4):733-63. PubMed ID: 11652212
    [No Abstract]   [Full Text] [Related]  

  • 29. International perceptions and approval of gene therapy.
    Macer DR; Akiyama S; Alora AT; Asada Y; Azariah J; Azariah H; Boost MV; Chatwachirawong P; Kato Y; Kaushik V
    Hum Gene Ther; 1995 Jun; 6(6):791-803. PubMed ID: 7548279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
    Krimsky S
    Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
    [No Abstract]   [Full Text] [Related]  

  • 31. The development of regulatory standards for gene therapy in the European Union.
    De Jager CF
    Fordham Int Law J; 1995 Apr; 18(4):1303-39. PubMed ID: 11657449
    [No Abstract]   [Full Text] [Related]  

  • 32. Biosafety code gathers pace through bilateral agreements.
    Dickson D
    Nature; 1995 Sep; 377(6545):94. PubMed ID: 7675091
    [No Abstract]   [Full Text] [Related]  

  • 33. Fears mount for gene scrutiny as watchdog faces axe.
    Kiernan V
    New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540
    [No Abstract]   [Full Text] [Related]  

  • 34. Prenatal gene tranfer: scientific, medical, and ethical issues: a report of the Recombinant DNA Advisory Committee.
    U.S. National Institutes of Health. Recombinant DNA Advisory Committee
    Hum Gene Ther; 2000 May; 11(8):1211-29. PubMed ID: 11660775
    [No Abstract]   [Full Text] [Related]  

  • 35. Ethical and regulatory issues in gene therapy.
    Nicholson S; Pandha HS; Harris JD; Waxman J
    Br J Urol; 1995 Nov; 76 Suppl 2():71-4. PubMed ID: 8535759
    [No Abstract]   [Full Text] [Related]  

  • 36. Human gene therapy and congress.
    Cook-Deegan RM
    Hum Gene Ther; 1990; 1(2):163-70. PubMed ID: 2078577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the report, Splicing Life.
    Capron AM
    Hum Gene Ther; 1990; 1(1):69-71. PubMed ID: 2081188
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical considerations in the design of protocols for somatic gene therapy.
    Ledley FD
    Hum Gene Ther; 1991; 2(1):77-83. PubMed ID: 1863643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human gene therapy: must we know where to stop before we start?
    Krimsky S
    Hum Gene Ther; 1990; 1(2):171-3. PubMed ID: 2078578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human gene therapy: a biopolitical overview and analysis.
    Carmen IH
    Hum Gene Ther; 1993 Apr; 4(2):187-93. PubMed ID: 8494928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.